Candida glabrata: In vitro susceptibility of 84 isolates to eight antifungal agents

Chemotherapy

Volumn 42, Issue 2, 1996, Pages 107-111

  Arias, Amgeles ^a   Arevalo M P ^a   Andreu, A ^b   Rodriguez C ^a   Sierra, A ^a,b  

^a UNIVERSIDAD DE LA LAGUNA   (Spain)

^b HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

Author keywords

Antifugal agent; Broth dilution; Candida glabrata; Microplate method; Susceptibility test

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; CLOTRIMAZOLE; ECONAZOLE; FLUCONAZOLE; ITRACONAZOLE; MICONAZOLE; TIOCONAZOLE;

ARTICLE; CANDIDA GLABRATA; CONTROLLED STUDY; DILUTION; DRUG ACTIVITY; DRUG RESISTANCE; DRUG SENSITIVITY; NONHUMAN; PRIORITY JOURNAL; UNIVERSITY HOSPITAL;

EID: 0030027089     PISSN: 00093157     EISSN: 14219794     Source Type: Journal    
DOI: 10.1159/000239429     Document Type: Article

References (32)

1. Wiensinfeld HC, Berg SR, Sweet RL: Torulopsis glabrala pelvic abscess and fungemia. Obstet Gynecol 1994;83:887-889.
2. Frye KR, Donovan JM, Drach GM: Torulopsis glabrala urinary infections: A review. J Urol 1988; 139: 1245-1249.
3. Valero-Gasalla J, Vazquez-Barro A, Palacios-Vallino P, Pousa-Rcal F: Torula glabrala: A severe and rare complication in patients suffering from bums. Burns 1992;18:76-77.
4. Fromtling RA, Galgiani JN, Pfaller MA, et al: Multicenter evaluation of a broth microdilution antifungal susceptibility test for yeast. Antimi-crob Agents Chemother 1993;37: 39-45.
5. Pfaller MA, Bale M, Buschelman B, Lancaster M, Espinel-Ingroff A, Rex JH, Rinaldi MG: Selection of candidate quality control isolates and tentative quality control ranges for in vitro susceptibility testing of yeast isolates by National Committee for Clinical Laboratory' Standards proposed standard methods. J Clin Microbiol 1994;32:1650-1653.
6. Land G A, Salkin IF, El-Zaatari M, McGinnis MR, Hashem G: Evaluation of the Baxtcr-MicroScan 4-hour enzyme-based yeast identification system. J Clin Microbiol 1991;29: 718-722.
7. St. Germain G, Beauchesne D: Evaluation of the MicroScan rapid yeast identification panel. J Clin Microbiol 1991;29:2296-2299.
8. Shadomy S: In vitro studies with 5-fluorocytosine. Appl Microbiol 1969;17:871-877.
9. Shadomy S, Pfaller MA: Laboratory studies with antifungal agents: Susceptibility test and quantification in body fluids; in Ballows A, Hausler WJ Jr, Herrman KL, Isenberg HD, Shadomy HJ (eds): Manual of Clinical Microbiology. Washington, American Society for Microbiology, 1991, pp 1173-1183.
10. Odds FC: Candida and Candidosis, ed 2. London, Balliere Tindall, 1988. pp 207-229.
11. Denning DW, Tucker RM, Hanson LH, Hamilton JR, Stevens DA: Itraconazole therapy for cryptococcal meningitis and cryptococcosis. Arch Intern Med 1989;149:2301-2308.
12. Dermoumi H: In vitro susceptibility of fungal isolates of clinically important specimens to itraconazole, fluconazole and amphotericin B. Chemotherapy 1994;40:92-98.
13. Polack A, Dixon DM: In vitro/in vivo correlation of antifungal susceptibility testing using 5-fluorocy-tosine and ketoconazole as example of two extremes; in Fromtling RA (ed): Recent Trends in the Discovery, Development and Evaluation of Antifungal Agents. Barcelona, Prous Science Publishers, 1987, pp 45-58.
14. Korting HS, Ollert M, Georgil A, Froschli M: In vitro susceptibilities and biotypes of Candida albicans isolates from the oral cavities of patients infected with human immunodeficiency virus. J Clin Microbiol 1988;26:2626-2631.
15. Odds FC: Antifungal susceptibility testing of Candida spp. by relative growth measurement at single concentrations of antifungal agents. An-timicrob Agents Chemother 1992; 36:1726-1737.
16. Arévalo MP, Arias A, Andreu A, Rodriguez C, Sierra A: Fluconazole, itraconazole and ketoconazole in vitro activity against Candida spp. 3 Chemother 1994;6:226-229.
17. Arévalo MP, Arias A, Andreu A, Rodriguez C, Sierra A: Sensibilité in vitro dc 84 isolates de Candida tropicalis à huit antifongiques. J Mycol Méd 1994;4:157-161.
18. Barchiesi F, Colombo AL, McGough DA, Rinaldi MG: Comparative study of broth macrodilu-tion and microdilution techniques for in vitro antifungal susceptibility testing of yeast by using the National Committee for Clinical Laboratory Standards proposed standard. J Clin Microbiol 1994;32:2494-2500.
19. Moracc G, Manzara S, Dettori G: In vitro susceptibility of 119 yeast isolates to fluconazole, 5-fluorocyto-sine, amphotericin B and ketoconazole. Chemotherapy 1991;37:23-31.
20. Marriot MS, Richardson K: The discovery and mode of action of fluconazole; in Fromtling RA (ed): Recent Trends in the Discovery, Development and Evaluation of Antifungal Agents. Barcelona, Prous Science Publishers, 1987, pp 81-92.
21. Martin E, Parras P, Lozano MC: In vitro susceptibility of 245 yeast isolates to amphotericin B, 5-fluorocy-tosine, ketoconazole, fluconazole and itraconazole. Chemotherapy 1992;38:335-339.
22. Pfaller MA, Barry L: Evaluation of a novel colorimetric broth microdilu-tion method for antifungal susceptibility testing of yeast isolates. J Clin Microbiol 1994;32:1992-1996.
23. Bramer KW, Farrow PR, Faulkner JK: Pharmacokinetics and tissue penetration of fluconazole in humans. Rev Infect Dis 1990; 12:318-326.
24. Gordon MA, Lapa MA, Passero PG: Improved method for azole antifungal susceptibility testing. J Clin Microbiol 1988;26:1874-1877.
25. Dennig DW, Tucker RM, Hanson LH: Itraconazole therapy for cryptococcal meningitis and cryptococcosis. Arch Intern Med 1989,149: 2301-2308.
26. Espinel-Ingroff A, Shadomy S, Geb-hart RJ: In vitro studies with R 51.211 (itraconazole). Antimicrob Agents Chemother 1984;26:5-9.
27. Hernández-Molina JM, Llosá J, Martínez-Brocal A, de la Rosa M: Sensibilidad de levaduras del genero Candida a nuevos agentes antifúngi-cos. Enform Infecc Microbiol Clin 1991;9:405-408.
28. Heel RC, Carmine A, Morley PA, Speight TM, Avery GS: Ketoconazole. A review of its therapeutic efficacy in superficial and systemic fungal infections. Drugs 1982;23:1-36.
29. Espinel-Ingroff A, Kcrkkering TM, Golson PR, Shadomy S: Comparison study of broth macrodilution and microdilution antifungal susceptibility test. J Clin Microbiol 1991;29:1089-1094.
30. Yamaguchi H, Uchida K, Hiratani T, Hara T, Fukuyasu H, Kazuno Y, Inouye S: In vitro activity of ME 1401, a new antifungal agent. Antimicrob Agents Chemother 1986; 30:705-712.
31. Crissold SP, Heel RC: Tioconazole: A Review of its antimicrobial activity and therapeutic use in superficial mycoses. Drugs 1986;31:29-51.
32. Riviera L, Bcllotti MG, Pestellini V, Giannotti D, Giolitti A, Fantó N: New benzofuran-imidazoles as anti-mycotic agents. II. In vitro studies. Chemioterapia 1987;6:272-276.